Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: An increasing problem

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Vanegas, Johanna M ^a   Parra, O Lorena ^a   Jiménez, J Natalia ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Carbapenem resistance; Gram negative bacilli; Infections in children

Indexed keywords

AMIKACIN; CARBAPENEM; CARBAPENEMASE; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; ERTAPENEM; GLYCOPEPTIDE; IMIPENEM; LINCOSAMIDE; LIPOPEPTIDE; MACROLIDE; MEROPENEM; MONOBACTAM DERIVATIVE; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CATHETER INFECTION; COLOMBIA; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENTEROBACTER CLOACAE; GRAM NEGATIVE BACTERIUM; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICAL RECORD; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; PNEUMONIA; POLYMERASE CHAIN REACTION; PROGNOSIS; PSEUDOMONAS AERUGINOSA; SKIN INFECTION; SOFT TISSUE INFECTION; SURGICAL INFECTION; TERTIARY CARE CENTER; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA; ANTIBIOTIC RESISTANCE; BACTEREMIA; CHILD; CROSS INFECTION; DRUG EFFECTS; FEMALE; GENETICS; HOSPITALIZED CHILD; INFANT; MALE; MICROBIOLOGY; PRESCHOOL CHILD; SECRETION (PROCESS);

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CHILD; CHILD, HOSPITALIZED; CHILD, PRESCHOOL; COLOMBIA; CROSS INFECTION; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; HUMANS; INFANT; MALE; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; TERTIARY CARE CENTERS;

EID: 84987761264     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1805-7     Document Type: Article

References (50)

1. Berezin EN, Solórzano F, Resistance LAWGoB. Gram-negative infections in pediatric and neonatal intensive care units of Latin America. J Infect Dev Ctries. 2014;8:942-53.
2. Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future. Antimicrob Agents Chemother. 2011;55:4943-60.
3. Morrill HJ, Pogue JM, Kaye KS, LaPlante KL. Treatment options for carbapenem-resistant enterobacteriaceae infections. Open Forum Infect Dis. 2015;2:ofv050.
4. Huang SR, Liu MF, Lin CF, Shi ZY. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections. J Microbiol Immunol Infect. 2014;47:187-96.
5. World Health Organization. Antimicrobial Resistance. Global Report on Surveillance. 2014. Accessed 20 Jun 2014.
6. Logan LK. Carbapenem-resistant enterobacteriaceae: an emerging problem in children. Clin Infect Dis. 2012;55:852-9.
7. Rojas MA, Efird MM, Lozano JM, Bose CL, Rojas MX, Rondón MA, et al. Risk factors for nosocomial infections in selected neonatal intensive care units in Colombia. South America J Perinatol. 2005;25:537-41.
8. Vanegas JM, Cienfuegos AV, Ocampo AM, López L, del Corral H, Roncancio G, et al. Similar frequencies of Pseudomonas aeruginosa isolates producing KPC and VIM carbapenemases in diverse genetic clones at tertiary-care hospitals in Medellín, Colombia. J Clin Microbiol. 2014;52:3978-86.
9. Hernández C, Blanco V, Motoa G, Correa A, Maya JJ, de la Cadena E, et al. Evolución de la resistencia antimicrobiana de bacilos Gram negativos en unidades de cuidados intensivos en Colombia. Biomedica. 2014;34(Supl. 1):91-100.
10. Escobar Pérez JA, Olarte Escobar NM, Castro-Cardozo B, Valderrama Márquez IA, Garzón Aguilar MI, Martinez de la Barrera L, et al. Outbreak of NDM-1-producing Klebsiella pneumoniae in a neonatal unit in Colombia. Antimicrob Agents Chemother. 2013;57:1957-60.
11. Candevir Ulu A, Kurtaran B, Inal AS, Kömür S, Kibar F, Yapici Çiçekdemir H, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs. Med Sci Monit. 2015;21:219-24.
12. Tängdén T, Giske CG. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. J Intern Med. 2015;277:501-12.
13. Vélez Echeverri C, Serna-Higuita LM, Serrano AK, Ochoa-García C, Rojas Rosas L, María Bedoya A, et al. Resistance profile for pathogens causing urinary tract infection in a pediatric population, and antibiotic treatment response at a university hospital, 2010-2011. Colomb Med (Cali). 2014;45:39-44.
14. Sharland M, Saroey P, Berezin EN. The global threat of antimicrobial resistance - The need for standardized surveillance tools to define burden and develop interventions. J Pediatr (Rio J). 2015;91:410-2.
15. CLSI. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Second Informational Supplement. CLSI document M100-S22. 2012.
16. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-32.
17. Ellington MJ, Kistler J, Livermore DM, Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother. 2007;59:321-2.
18. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70:119-23.
19. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol. 2004;42:5644-9.
20. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43:4178-82.
21. Villalobos AP, Barrero LI, Rivera SM, Ovalle MV, Valera D. Surveillance of healthcare associated infections, bacterial resistance and antibiotic consumption in high-complexity hospitals in Colombia, 2011. Biomedica. 2014;34 Suppl 1:67-80.
22. Salud OPdl. Vigilancia epidemiológica de las infecciones asociadas a la atención de la salud. Módulo III: información para gerentes y personal directivo Washington; 2012. [Available from: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=19272&Itemid= Accessed 12 Jun 2014.
23. Arnoni MV, Berezin EN, Martino MD. Risk factors for nosocomial bloodstream infection caused by multidrug resistant gram-negative bacilli in pediatrics. Braz J Infect Dis. 2007;11:267-71.
24. Patel SJ, O'Toole D, Larson E. A new metric of antibiotic class resistance in gram-negative bacilli isolated from hospitalized children. Infect Control Hosp Epidemiol. 2012;33:602-7.
25. Abramczyk ML, Carvalho WB, Carvalho ES, Medeiros EA. Nosocomial infection in a pediatric intensive care unit in a developing country. Braz J Infect Dis. 2003;7:375-80.
26. Zorc JJ, Kiddoo DA, Shaw KN. Diagnosis and management of pediatric urinary tract infections. Clin Microbiol Rev. 2005;18:417-22.
27. Barreto S, Zambrano M, Araque M. Phenotypic variations of susceptibility in Klebsiella pneumoniae strains of nosocomial origin and their association with biofilm formation. Invest Clin. 2009;50:221-9.
28. Pérez-González LF, Ruiz-González JM, Noyola DE. Nosocomial bacteremia in children: a 15-year experience at a general hospital in Mexico. Infect Control Hosp Epidemiol. 2007;28:418-22.
29. Holt AF VI't, Severin JA, Lesaffre EM, Vos MC. A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2014;58:2626-37.
30. McLaughlin M, Advincula MR, Malczynski M, Qi C, Bolon M, Scheetz MH. Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae. Antimicrob Agents Chemother. 2013;57:5131-3.
31. Versporten A, Sharland M, Bielicki J, Drapier N, Vankerckhoven V, Goossens H, et al. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J. 2013;32:242-53.
32. Gibson MK, Crofts TS, Dantas G. Antibiotics and the developing infant gut microbiota and resistome. Curr Opin Microbiol. 2015;27:51-6.
33. Strenger V, Feierl G, Resch B, Zarfel G, Grisold A, Masoud-Landgraf L, et al. Fecal carriage and intrafamilial spread of extended-spectrum β-lactamase-producing enterobacteriaceae following colonization at the neonatal ICU. Pediatr Crit Care Med. 2013;14:157-63.
34. Çoban B, Ülkü N, Kaplan H, Topal B, Erdoan H, Baskin E. Five-year assessment of causative agents and antibiotic resistances in urinary tract infections. Turk Pediatri Ars. 2014;49:124-9.
35. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18:263-72.
36. KPC-2 gene in Colombia. Antimicrob Agents Chemother. 2011;55:5350-3.
37. Lee GC, Burgess DS. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports. Ann Clin Microbiol Antimicrob. 2012;11:32.
38. Cao X, Xu X, Zhang Z, Shen H, Chen J, Zhang K. Molecular characterization of clinical multidrug-resistant Klebsiella pneumoniae isolates. Ann Clin Microbiol Antimicrob. 2014;13:16.
39. Pogue JM, Lee J, Marchaim D, Yee V, Zhao JJ, Chopra T, et al. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis. 2011;53:879-84.
40. Díaz A, Ortiz DC, Trujillo M, Garcés C, Jaimes F, Gouzy AR. Clinical Characteristics of Carbapenem Resistant Klebsiella pneumoniae Infections in Ill and Colonized Children in Colombia. Pediatr Infect Dis J. 2016;35(3):237-41. doi: 10.1097/INF.0000000000000987.
41. Lee JY, Ko KS. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Int J Antimicrob Agents. 2012;40(2):168-72.
42. Chung HS, Yong D, Lee M. Mechanisms of ertapenem resistance in Enterobacteriaceae isolates in a tertiary university hospital. J Investig Med. 2016;64:1042.
43. Arena F, Giani T, Becucci E, Conte V, Zanelli G, D'Andrea MM, et al. Large oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit. J Clin Microbiol. 2013;51:4067-72.
44. Mshana SE, Hain T, Domann E, Lyamuya EF, Chakraborty T, Imirzalioglu C. Predominance of Klebsiella pneumoniae ST14 carrying CTX-M-15 causing neonatal sepsis in Tanzania. BMC Infect Dis. 2013;13:466.
45. NDM-1 in Klebsiella pneumoniae Isolated in Singapore. Microb Drug Resist. 2016;22(2):109-14. doi: 10.1089/mdr.2015.0132.
46. Stillwell T, Green M, Barbadora K, Ferrelli JG, Roberts TL, Weissman SJ, et al. Outbreak of KPC-3 Producing Carbapenem-Resistant Klebsiella pneumoniae in a US Pediatric Hospital. J Pediatric Infect Dis Soc. 2015;4:330-8.
47. Giuffrè M, Bonura C, Geraci DM, Saporito L, Catalano R, Di Noto S, et al. Successful control of an outbreak of colonization by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae sequence type 258 in a neonatal intensive care unit, Italy. J Hosp Infect. 2013;85:233-6.
48. Ocampo AM, Chen L, Cienfuegos AV, Roncancio G, Chavda KD, Kreiswirth BN, et al. High frequency of non-CG258 clones of carbapenem-resistant Klebsiella pneumoniae with distinct clinical characteristics: A two-year surveillance in five Colombian tertiary care hospitals. Antimicrob Agents Chemother. 2015;60:332-42.
49. Maldonado NA, Múnera MI, López JA, Sierra P, Robledo C, Robledo J, et al. Trends in antibiotic resistance in Medellín and municipalities of the Metropolitan Area between 2007 and 2012: Results of six years of surveillance. Biomedica. 2014;34(3):433-46.
50. Vanegas JM, Higuita LF, Vargas C, Cienfuegos AV EAR, Roncancio GE, et al. Carbapenem resistant Acinetobacter baumannii causing osteomyelitis and skin and soft tissue infections in hospitals in Medellín, Colombia. Biomedica. 2015;35(4):522.